Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Abnormal ryanodine receptor function in heart failure.

Masafumi Yano1, Takeshi Yamamoto, Noriaki Ikemoto

  • 1Department of Medical Bioregulation, Division of Cardiovascular Medicine, Yamaguchi University School of Medicine, Yamaguchi, Japan. yanoma@po.cc.yamaguchi-u.ac.jp

Pharmacology & Therapeutics
|June 14, 2005
PubMed
Summary

Abnormal calcium release from the sarcoplasmic reticulum (SR) causes heart failure. Ryanodine receptor (RyR) dysfunction, due to altered protein interactions and phosphorylation, is a key factor in heart disease and arrhythmias.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of Empagliflozin on Device-Measured Thoracic Impedance in Patients With Type 2 Diabetes Treated With an Implantable Cardioverter Defibrillator.

Circulation·2026
Same author

Redox-controlled near-infrared-to-near-infrared optical switching in TPA dimers.

Physical chemistry chemical physics : PCCP·2026
Same author

Crystal structure of tris-[4-(3,4-di-meth-oxy-thio-phen-2-yl)phen-yl]amine.

Acta crystallographica. Section E, Crystallographic communications·2026
Same author

Association between baseline white blood cell count and future cardiovascular events in patients with stable coronary artery disease- Sub-analysis of the REAL-CAD trial.

American journal of preventive cardiology·2025
Same author

Catecholaminergic polymorphic ventricular tachycardia-linked ryanodine receptor variants exhibit domain-specific calcium leak and calmodulin affinity properties.

The Journal of physiology·2025
Same author

Concurrent Large-vessel Vasculitis and Small-vessel Vasculitis Accompanied by Basal Cell Carcinoma.

Internal medicine (Tokyo, Japan)·2025

Area of Science:

  • Cardiovascular Physiology
  • Molecular Cardiology
  • Cardiac Electrophysiology

Background:

  • Heart failure (HF) involves abnormal calcium (Ca2+) release from the sarcoplasmic reticulum (SR), impairing cardiac function.
  • Protein kinase A (PKA)-mediated hyperphosphorylation of the ryanodine receptor (RyR) leads to FK506 binding protein (FKBP) 12.6 dissociation in HF.
  • This dissociation causes abnormal Ca2+ leak, affecting diastolic Ca2+ levels and re-uptake, contributing to contractile dysfunction.

Purpose of the Study:

  • To review the role of abnormal ryanodine receptor (RyR) function in the pathogenesis of heart failure (HF).
  • To discuss recent findings on RyR mutations linked to cardiac arrhythmias like CPVT and ARVD2.
  • To explore the concept of interdomain interactions in RyR channel regulation and dysfunction.

Main Methods:

Related Experiment Videos

  • Literature review of recent studies on RyR function, phosphorylation, and associated proteins in cardiac disease.
  • Analysis of mutation sites within RyR domains to understand interdomain interactions.
  • Discussion of controversial aspects, including the roles of phosphorylation and FKBP12.6.

Main Results:

  • Abnormal Ca2+ handling via RyR is a significant contributor to heart failure pathogenesis.
  • Disease-linked RyR mutations suggest that interdomain interactions are critical for channel regulation.
  • Altered RyR function, phosphorylation, and FKBP12.6 dissociation are implicated in HF and arrhythmias.

Conclusions:

  • Abnormal ryanodine receptor (RyR) function is central to heart failure and certain cardiac arrhythmias.
  • Understanding RyR's interdomain interactions and post-translational modifications offers potential therapeutic targets.
  • Further research into pharmacological and genetic strategies targeting RyR may lead to novel treatments for cardiac conditions.